General Information of the Compound
| Compound ID |
CP0420924
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5Z)-5-[(3,4-dimethoxyphenyl)methylidene]-3-[3-(4-pyrimidin-2-ylpiperazin-1-yl)propyl]imidazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C23H28N6O4
|
||||||||||||||||||
| Molecular Weight |
452.515
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(\C=C2/NC(=O)N(CCCN3CCN(CC3)c3ncccn3)C2=O)cc1OC
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C23H28N6O4/c1-32-19-6-5-17(16-20(19)33-2)15-18-21(30)29(23(31)26-18)10-4-9-27-11-13-28(14-12-27)22-24-7-3-8-25-22/h3,5-8,15-16H,4,9-14H2,1-2H3,(H,26,31)/b18-15-
Show/Hide
|
||||||||||||||||||
| InChIKey |
SVTUIXLXBYRLKI-SDXDJHTJSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00941, 5-hydroxytryptamine receptor 7